Human iPSC-Derived Neural Stem Cells - Trisomy X Patient. 1 vial of Neural Stem Cells (1.5 million cells/vial) and Neural Plating-XF Medium (30 mL).
Trisomy X (Triple X) syndrome occurs at a frequency of approximately 1 in 1000 newborn females. The syndrome is associated with an increased risk of seizures and may affect short-term memory and learning although the majority of women affected show few clinical symptoms. Axol has developed iPSC-derived neural stem cells from a patient with the triple X chromosomal abnormality. All of the iPS cells examined (20 individual cells karyotyped), had trisomy X.
Donor age at sampling
Trisomy X (47, XXX)
Monolayer & chemically defined medium
≥1.5 million cells
iPSC-derived neural stem cells